Health

Novartis raised its medium-term sales forecast to 6% annual growth until 2028, driven by momentum from launched drugs and the prospect of upcoming launches. The

Upcoming data from a mid-stage study of Amgen’s experimental weight-loss drug MariTide will shed light on how well it could measure up against popular drugs

Elon Musk’s Neuralink said it received approval to launch its first clinical trial in Canada for a device designed to give paralysed people the ability

Pfizer named company veteran Chris Boshoff, who led the drugmaker’s cancer research and marketing for more than a year, as its head of research and

California’s public health department reported a possible case of bird flu in a child with mild respiratory symptoms, but said there was no evidence of

Thousands of Italian doctors and nurses stayed off work on Wednesday to protest over their pay and working conditions, in the latest sign of unrest

The highest dose of an experimental pill developed by Eli Lilly dramatically reduced an inherited form of high cholesterol in a mid-stage trial. The drug,

Merck said on Tuesday that a study showed its injectable version of the cancer drug Keytruda was not inferior to the currently approved intravenous formulation

Novo Nordisk launched its weight-loss drug Wegovy in China after it was approved by local health authorities in June. It is expected to intensify competition

Danish biotech Bavarian Nordic said the order book for the supply of its mpox and smallpox vaccine in 2025 currently stands at about $340 million.